Michael Capaldi

Title: Michael Capaldi: Innovator in Antibody Technology

Introduction

Michael Capaldi is a notable inventor based in Malvern, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of antibody production. His innovative work has led to advancements that benefit both research and therapeutic applications.

Latest Patents

Michael Capaldi holds a patent for a process titled "Process for preparing unaggregated antibody Fc domains." This patent describes methods useful for producing a solution of purified Fc peptide chains. The methods utilize protein A chromatography to effectively separate high molecular weight, aggregated peptide chains from lower molecular weight unaggregated peptide chains. The solutions obtained through this process contain less than 5% aggregate and greater than 70% of the Fc peptide chains subjected to purification.

Career Highlights

Michael Capaldi is currently employed at Janssen Biotech, Inc., where he continues to work on innovative solutions in biotechnology. His expertise in antibody technology has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Michael has collaborated with talented individuals such as Joshua Goldstein and Nicole Quinlan. These partnerships have fostered a collaborative environment that enhances the development of new technologies.

Conclusion

Michael Capaldi's contributions to antibody technology exemplify the impact of innovation in biotechnology. His work not only advances scientific understanding but also paves the way for future developments in therapeutic applications.